Psychae Therapeutics
Carlton
About Psychae Therapeutics
Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.9M
- Funding stage: Seed
- Last round: Pre-Seed (Nov 2023)
- Website: psychae.bio
- Phone: 94 657 032 251
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/psychae-therapeutics-197199 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.